Видео с ютуба Elacestrant

Elacestrant - Not Just for ESR1 Mutations

First Oral Pill For Breast Cancer: Elacestrant FDA Approved! #shorts

Elacestrant: First Oral SERD for Advanced Breast Cancer #shorts

New Breast Cancer Drug Extends Lives: Elacestrant & Emlunestrant Advance #shorts

Можно ли принимать таблетки вместо инъекций при раке груди?

ERADICATE: elacestrant plus trastuzumab deruxtecan in HR+/HER2-low mBC

Social Media Tied to Inattention, GRB 250702B Blows Away Models, Elacestrant Combo Boosts Surviva...

Bethany: My self-care routine for mBC

ELEMENT-Studie:Hormonrezeptorpositiver,HER2-negativer,metastasierter Brustkrebs mit Keimbahnmutation

Sherri’s ORSERDU (elacestrant) Story | ESR1 Testing and Disease Progression

Experiences With Oral SERDs for HR+/HER2- Metastatic Breast Cancer

Bethany’s ORSERDU Story | Why ESR1 Matters To Me

Svolta nel Tumore al Seno Metastatico, Nuove Terapie

Tumori: carcinoma mammario metastatico, disponibile nuova terapia ormonale mirata

Tumori: oncologa Del Mastro, ‘elacestrant passo avanti in cura cancro seno metastatico’ 

ORSERDU® (elacestrant) tablets Indication and Important Safety Information

The ORSERDU Patient

#ASCO25 | I risultati dello studio ELEVATE | Michelino De Laurentiis

Oral SERDs Explained: A New Option for Breast Cancer Patients

Elacestrant in ER+/HER2- mBC with ESR1-mut tumors: Overview of the EMERALD subgroup analyses